Skip to main content
Walvax Biotechnology Co.,Ltd. logo

Walvax Biotechnology Co.,Ltd. — Investor Relations & Filings

Ticker · 300142 ISIN · CNE100000WN2 LEI · 300300H82R2DIQXA8N24 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,790 across all filing types
Latest filing 2026-01-08 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 300142

About Walvax Biotechnology Co.,Ltd.

https://www.walvax.com

Walvax Biotechnology Co.,Ltd. is a biopharmaceutical enterprise specializing in the research, development, production, and distribution of vaccines and other biological products. The company focuses on modern biotechnology to address public health challenges through a diverse portfolio of preventive vaccines. Key products include the 13-valent pneumococcal polysaccharide conjugate vaccine (PCV13), the bivalent human papillomavirus (HPV) vaccine, and various combination vaccines for meningitis and Haemophilus influenzae type b (Hib). Walvax operates advanced R&D platforms and manufacturing facilities that comply with international quality standards. The company is actively involved in the development of next-generation vaccine technologies, including mRNA and recombinant protein platforms, aiming to provide affordable and high-quality immunization solutions for global markets.

Recent filings

Filing Released Lang Actions
关于向银行申请并购借款并质押子公司部分股权的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by a company regarding its application for a merger and acquisition (M&A) loan and the pledge of subsidiary shares as collateral. It details the loan contract, pledge contract, background of the M&A loan, and board resolutions approving the financing. The document does not contain financial statements or detailed financial performance data but rather focuses on the financing activity related to an acquisition. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes. The document length is about 5,487 characters, which is sufficient for a detailed announcement but not a full financial report. Therefore, the correct classification is CAP with high confidence.
2026-01-08 Chinese
独立董事提名人声明与承诺（二）
Board/Management Information Classification · 95% confidence The document is a formal statement and commitment regarding the nomination of an independent director candidate for the company's board. It includes detailed declarations about the nominee's qualifications, compliance with relevant laws and regulations, and independence criteria. There are no financial statements, earnings data, or report summaries. The content is focused on board/management information, specifically about director nomination and related compliance. The document length is 4664 characters, which is sufficient for a detailed nomination statement but does not constitute a full report like an annual report or interim report. Therefore, the document fits best under the category of Board/Management Information (MANG).
2026-01-08 Chinese
独立董事提名人声明与承诺（三）
Regulatory Filings Classification · 95% confidence The document is a formal statement and commitment regarding the nomination of an independent director candidate for the company's board. It details qualifications, compliance with laws and regulations, and declarations related to the nominee's independence and eligibility. There is no financial data, no report of financial performance, no voting results, no management changes announcement, and no mention of a meeting or shareholder vote results. The document is a regulatory compliance statement related to board nominations, which fits best under Regulatory Filings (RNS) as it does not fit other more specific categories.
2026-01-08 Chinese
独立董事提名人声明与承诺（四）
Board/Management Information Classification · 95% confidence The document is a formal statement and commitment regarding the nomination of an independent director candidate for the company's board. It includes detailed declarations about the nominee's qualifications, compliance with relevant laws and regulations, and independence criteria. There are no financial statements, earnings data, or report summaries. The content focuses on board/management information, specifically about director nomination and qualifications. Therefore, it fits the category of Board/Management Information (MANG). The document length is moderate and contains detailed declarations rather than a brief announcement or a report publication notice.
2026-01-08 Chinese
独立董事提名人声明与承诺（一）
Board/Management Information Classification · 95% confidence The document is a detailed statement and commitment regarding the nomination of an independent director candidate for the company's board. It includes declarations about the nominee's qualifications, compliance with relevant laws and regulations, and independence criteria. There is no financial data, earnings information, or report publication mentioned. The content focuses on board/management changes and governance compliance related to the nomination of a director. Therefore, the document fits best under the category of Board/Management Information (MANG). The document length is moderate and contains detailed declarations rather than a brief announcement or a report publication notice.
2026-01-08 Chinese
独立董事候选人声明与承诺（赵健梅）
Board/Management Information Classification · 95% confidence The document is a detailed declaration and commitment statement by an independent director candidate for a company's board. It includes statements of compliance with legal and regulatory requirements, qualifications, and independence criteria. There are no financial statements, earnings data, or report summaries. The content is focused on board/management information, specifically about the nomination and qualifications of an independent director candidate. This fits the category of Board/Management Information (MANG). The document length is under 5,000 characters but contains substantive content about management nomination rather than a brief announcement or report publication. Therefore, it is not a report publication announcement or regulatory filing. Hence, the classification is MANG with high confidence.
2026-01-08 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.